December 19, 2020 by Fightec.org
https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-FDA-Grants-Priority-Review-to-Keytruda-Plus-Chemotherapy-to-Treat-Types-of-Gastrointestinal-32035233/